PedvaxHIB - 0006-4897-00 - (Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate))

Alphabetical Index


Drug Information of PedvaxHIB

Product NDC: 0006-4897
Proprietary Name: PedvaxHIB
Non Proprietary Name: Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)
Active Ingredient(s): 7.5    ug/.5mL & nbsp;   Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)
Administration Route(s): INTRAMUSCULAR
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of PedvaxHIB

Product NDC: 0006-4897
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: VACCINE
FDA Application Number: BLA103237
Marketing Category: BLA
Start Marketing Date: 19891220

Package Information of PedvaxHIB

Package NDC: 0006-4897-00
Package Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4897-00) > .5 mL in 1 VIAL, SINGLE-DOSE

NDC Information of PedvaxHIB

NDC Code 0006-4897-00
Proprietary Name PedvaxHIB
Package Description 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4897-00) > .5 mL in 1 VIAL, SINGLE-DOSE
Product NDC 0006-4897
Product Type Name VACCINE
Non Proprietary Name Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)
Dosage Form Name INJECTION, SUSPENSION
Route Name INTRAMUSCULAR
Start Marketing Date 19891220
Marketing Category Name BLA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
Strength Number 7.5
Strength Unit ug/.5mL
Pharmaceutical Classes Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

Complete Information of PedvaxHIB


General Information